Holly has completed her initial assessment at Koru Spring, located at 1900 Corporate Square Blvd, FL 2, Jacksonville, FL 32216. During this session, Holly expressed her commitment to continue with her treatment, highlighting its significance in her journey towards recovery.
In her recent Eye Movement Desensitization and Reprocessing (EMDR) session, Holly gained valuable insights into some of the core beliefs she has been grappling with. She articulated her ongoing struggles with these beliefs, which indicates a significant level of awareness and engagement in her therapeutic process. This progress is crucial as it provides a foundation for further therapeutic work.
Holly has reported ongoing challenges with her mood, characterized by persistent feelings of depression and heightened anxiety. She expressed particular concern regarding her ability to maintain sobriety and abstain from eating disorder (ED) behaviors. These insights reveal the complexity of her mental health status and the interrelatedness of her symptoms.
During her assessment, Holly communicated her openness to exploring pharmacological interventions, specifically selective serotonin reuptake inhibitors (SSRIs), to address her anxiety and depressive symptoms. After careful consideration and clinical evaluation, it has been agreed upon to initiate treatment with Zoloft at a dosage of 50mg. Additionally, we will increase her current dosage of Abilify to 10mg to better support her mood stabilization.
The clinical team is committed to a collaborative approach in Holly's treatment plan, ensuring that she feels supported and involved in the decision-making process regarding her healthcare choices. This collaborative framework not only fosters trust but also empowers Holly to take an active role in her recovery journey.
Moving forward, the treatment team will monitor Holly’s response to the new medication regimen closely. Regular follow-up appointments will be scheduled to assess her progress, address any concerns, and make necessary adjustments to her treatment plan. The Therapeutic team will also continue to provide therapeutic support to further explore and address Holly's core beliefs as highlighted in her recent EMDR session.
Holly's initial assessment at Koru Spring marks an important step in her treatment journey. With her active participation and insights into her struggles, coupled with a carefully tailored medication management plan, we are optimistic about her continued progress. The clinical team remains dedicated to providing comprehensive support to assist Holly in achieving her therapeutic goals and enhancing her overall well-being.